Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

New research suggests a genetic mutation previously believed to promote esophageal cancer might actually play a protective ...

Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.